Vaccination of cattle with the N-terminus of L2 is necessary and sufficient for preventing infection by bovine papillomavirus-4

Virology. 1995 Aug 1;211(1):204-8. doi: 10.1006/viro.1995.1392.

Abstract

We have previously shown that cattle vaccinated with L2, the minor structural protein of bovine papillomavirus-4 (BPV-4), do not develop alimentary papillomas upon challenge with BPV-4. Analysis of the B and T cell response in L2-vaccinated animals showed that the majority of the response was directed against the N-terminus and C-terminus of L2 with little response against the middle portion. Cattle were vaccinated with the N-terminus or the C-terminus of L2. The animals vaccinated with the N-terminus were completely protected from viral challenge, whereas the animals vaccinated with the C-terminus were not. Further analysis with synthetic overlapping peptides spanning the entire N-terminus mapped a B cell immunodominant epitope at amino acid 101-120. This epitope was recognised by all vaccinated animals.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Antibody Formation
  • B-Lymphocytes / immunology*
  • Bovine papillomavirus 1 / immunology*
  • Bovine papillomavirus 4
  • Capsid / chemistry
  • Capsid / immunology*
  • Capsid Proteins*
  • Cattle
  • Epitopes / immunology
  • Lymphocyte Activation
  • Molecular Sequence Data
  • Open Reading Frames*
  • Papilloma / immunology*
  • Papilloma / prevention & control
  • Papillomavirus Infections / immunology*
  • Papillomavirus Infections / prevention & control
  • Peptides / chemical synthesis
  • Peptides / chemistry
  • Tumor Virus Infections / immunology*
  • Tumor Virus Infections / prevention & control
  • Vaccines, Synthetic / immunology*
  • Viral Structural Proteins / chemistry
  • Viral Structural Proteins / immunology
  • Viral Vaccines*

Substances

  • Capsid Proteins
  • Epitopes
  • L2 protein, Bovine papillomavirus
  • Peptides
  • Vaccines, Synthetic
  • Viral Structural Proteins
  • Viral Vaccines